Equities
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.

  • Revenue in USD (TTM)55.52bn
  • Net income in USD12.40bn
  • Incorporated1942
  • Employees78.50k
  • Location
    Pfizer Inc235 E 42ND STNEW YORK 10017-5703United StatesUSA
  • Phone+1 (212) 573-2323
  • Fax+1 (302) 655-5049
  • Websitehttps://www.pfizer.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PFE:NYQ since
announced
Transaction
value
Trillium Therapeutics IncAnnounced23 Aug 202123 Aug 2021Announced-11.43%2.12bn
Glaxosmithkline Plc- Consumer UnitAnnounced03 Jun 202103 Jun 2021Announced11.24%--
Amplyx Pharmaceuticals IncDeal completed28 Apr 202128 Apr 2021Deal completed12.22%--
Data delayed at least 15 minutes, as of Oct 25 2021 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bristol-Myers Squibb Co44.38bn-5.08bn127.99bn30.25k--3.4822.412.88-2.27-2.2719.6016.570.37164.326.161,467,240.00-4.242.55-5.153.1978.0272.44-11.405.971.42--0.5505192.9562.6220.75-362.14---1.693.99
Moderna Inc7.02bn3.49bn131.81bn1.30k40.7619.6336.6618.788.018.0116.9916.640.7149--6.845,399,735.0035.59--65.71--84.20--49.79--1.17--0.0677--1,234.34---45.34------
AbbVie Inc53.73bn6.60bn192.87bn48.00k29.3815.3412.493.593.723.7230.247.110.36124.955.881,143,170.004.497.735.479.7265.7173.8112.4218.070.78846.490.867197.1537.6914.91-41.90-2.408.4518.50
Merck & Co., Inc.47.10bn4.81bn205.42bn74.00k42.956.1725.074.361.892.1918.5613.150.51952.586.11636,418.905.317.267.039.4768.3369.5610.2314.951.06--0.442785.462.463.97-29.059.7329.566.62
Eli Lilly And Co26.73bn6.07bn233.17bn35.00k36.6436.1831.028.726.656.6529.306.740.59541.935.02763,608.6013.5210.2819.4914.5474.2777.1922.7119.520.8925--0.712556.069.954.2233.5520.794.538.16
Pfizer Inc.55.52bn12.40bn241.98bn78.50k19.723.4513.974.362.192.349.8112.510.31921.605.63707,261.107.164.818.935.9656.1878.9522.4317.451.12--0.3582100.531.79-3.02-33.570.109213.286.30
Data as of Oct 25 2021. Currency figures normalised to Pfizer Inc's reporting currency: US Dollar USD

Institutional shareholders

31.88%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 2021432.72m7.72%
SSgA Funds Management, Inc.as of 30 Jun 2021278.57m4.97%
BlackRock Fund Advisorsas of 30 Jun 2021262.07m4.67%
Wellington Management Co. LLPas of 30 Jun 2021241.72m4.31%
Capital Research & Management Co. (World Investors)as of 30 Jun 2021240.19m4.28%
Geode Capital Management LLCas of 30 Jun 202196.38m1.72%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 202164.25m1.15%
Norges Bank Investment Managementas of 31 Dec 202060.50m1.08%
State Farm Investment Management Corp.as of 30 Jun 202156.54m1.01%
Charles Schwab Investment Management, Inc.as of 30 Jun 202154.59m0.97%
More ▼
Data from 31 Dec 2020 - 30 Sep 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.